Literature DB >> 18711765

Symptom combinations assessed in traditional Chinese medicine and its predictive role in ACR20 efficacy response in rheumatoid arthritis.

Yiting He1, Aiping Lu, Cheng Lu, Yinglin Zha, Xiaoping Yan, Yuejin Song, Shengping Zeng, Wei Liu, Wanhua Zhu, Li Su, Xinghua Feng, Xian Qian, Ian Tsang.   

Abstract

The predictive roles of symptom combination traditionally evaluated in traditional Chinese medicine (TCM) in the treatment of rheumatoid arthritis (RA) were explored. Three hundred and ninety six patients were randomly divided into 197 subjects receiving Western medicine therapy (WM) and 199 subjects receiving TCM therapy (TCM). A complete physical examination and 18 clinical manifestations typically assessed in TCM were recorded before the randomization. The ACR responses were used for efficacy evaluation. ACR20 and 50 responses with WM treatment were higher than in the TCM group. The 18 symptoms in RA could be clustered into 4 symptom combinations with factor analysis, which represent joint symptoms, cold pattern, deficiency pattern and hot pattern in TCM respectively. TCM would be more effective in patients with weak-symptom combination 3 (deficiency pattern in TCM), and WM would be more effective in patients with symptom combination 2 (cold pattern in TCM). Symptom combinations judged with TCM may have influence on the efficacy of therapy in the treatment of RA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18711765     DOI: 10.1142/S0192415X08006144

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  12 in total

1.  Convergence: Where West meets East.

Authors:  Peng Tian
Journal:  Nature       Date:  2011-12-21       Impact factor: 49.962

Review 2.  Current situation and progress in integrative medicine in China.

Authors:  Ai-ping Lu; Xiao-rong Ding; Ke-ji Chen
Journal:  Chin J Integr Med       Date:  2008-10-14       Impact factor: 1.978

3.  Bridging the traditional Chinese medicine pattern classification and biomedical disease diagnosis with systems biology.

Authors:  Ai-ping Lu; Zhao-xiang Bian; Ke-ji Chen
Journal:  Chin J Integr Med       Date:  2012-12-13       Impact factor: 1.978

Review 4.  Syndrome pattern and its application in parallel randomized controlled trials.

Authors:  Byung-Cheul Shin; Sina Kim; Young-Hun Cho
Journal:  Chin J Integr Med       Date:  2012-12-03       Impact factor: 1.978

5.  Integration of Chinese medicine and Western medicine in clinical practice (patient care): past, present, and a proposed model for the future.

Authors:  Ian Tsang; Simon Huang; Barry Koehler
Journal:  Chin J Integr Med       Date:  2013-01-31       Impact factor: 1.978

6.  Insights of Chinese medicine syndrome study: from current status to future prospects.

Authors:  Zhao-xiang Bian; Hao Xu; Ai-ping Lu; Myeong Soo Lee; Hollie Cheung
Journal:  Chin J Integr Med       Date:  2014-05-02       Impact factor: 1.978

7.  Serum low-density lipoprotein and heart rate related to the effectiveness in the treatment of angina pectoris with two similar Chinese medicine herbal formulae.

Authors:  Shi-yan Yan; Chen Yao; Xiao-rong Ding; Miao Jiang; Ai-ping Lu
Journal:  Chin J Integr Med       Date:  2011-12-03       Impact factor: 1.978

8.  Differential Amino Acid, Carbohydrate and Lipid Metabolism Perpetuations Involved in a Subtype of Rheumatoid Arthritis with Chinese Medicine Cold Pattern.

Authors:  Hongtao Guo; Xuyan Niu; Yan Gu; Cheng Lu; Cheng Xiao; Kevin Yue; Ge Zhang; Xiaohua Pan; Miao Jiang; Yong Tan; Hongwei Kong; Zhenli Liu; Guowang Xu; Aiping Lu
Journal:  Int J Mol Sci       Date:  2016-10-21       Impact factor: 5.923

Review 9.  Systematic review of the methodological quality of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis.

Authors:  Xin Pan; Maria A Lopez-Olivo; Juhee Song; Gregory Pratt; Maria E Suarez-Almazor
Journal:  BMJ Open       Date:  2017-03-01       Impact factor: 2.692

10.  Predicting and verifying outcome of Tripterygium wilfordii Hook F. based therapy in rheumatoid arthritis: from open to double-blinded randomized trial.

Authors:  Miao Jiang; Qinglin Zha; Chi Zhang; Cheng Lu; Xiaoping Yan; Wanhua Zhu; Wei Liu; Shenghao Tu; Liping Hou; Chengwu Wang; Wandong Zhang; Qinghua Liang; Bing Fan; Jiangping Yu; Weidong Zhang; Xinru Liu; Jing Yang; Xiaojuan He; Li Li; Xuyan Niu; Yan Liu; Hongtao Guo; Bing He; Ge Zhang; Zhaoxiang Bian; Aiping Lu
Journal:  Sci Rep       Date:  2015-04-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.